Delivery Order SPE2DB22D1041-SPE2DB25FUCH0
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Guaifenesin 600mg tablets (500 count) with a ceiling value of $3,028.65. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion on May 20, 2025, and will be performed at AmerisourceBergen's Corporate Office location in...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Guaifenesin ER 600 mg tablets (500 count) with a ceiling value of $1,419.55. The contract was awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, and utilizes firm fixed pricing with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $737 delivery order to Amerisourcebergen Drug Corporation for 4561851739 GUAIFENESIN-PSE ER 600-60 MG 18S. The firm fixed price order is being fulfilled from the contractor's Conshohocken, Pennsylvania location to support DLA's medical supply needs. No additional details were provided regarding the original solicitation, but the award is for a pharmaceutical product to replenish Defense Department medical stock. Amerisourcebergen will serve as the prime...
- The Defense Logistics Agency awarded a $29,550 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200mg guaifenesin tablets. Under this order, Amerisourcebergen will deliver 100 bottles of the specified cough medication to a facility in Conshohocken, Pennsylvania by June 30, 2023 to support Department of Defense logistics operations. As a major pharmaceutical supplier, Amerisourcebergen frequently fulfills delivery orders for standard medical supplies through the DLA's...
- The Defense Logistics Agency awarded a $159.78 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561986410 GUAIFENESIN-PSE ER 600-60 MG 18S. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the specified pharmaceutical products under the contract's one-day period of performance from August 29, 2023 through August 30, 2023. The parent company, Amerisourcebergen Corporation, will support delivery from its Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a $3,013.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18-count units) on July 24, 2025, with completion targeted for July 25, 2025. This non-set-aside delivery order represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. The award was issued to AmerisourceBergen's Corporate Office division, with performance to occur at the company's headquarters in...
- The Defense Logistics Agency awarded a $1,101.28 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Mucinex D ER 1,200-120 mg tablets (24-count). This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency Troop Support Medical awarded a $266 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 600-60 milligram bottles of guaifenesin-pse extended release capsules. Place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania distribution facility. The single day order is under an indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen with the DLA for pharmaceutical products and services. No subcontractors...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count packages) with a ceiling value of $1,016.35. This competitive award, utilizing firm fixed pricing, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled from AmerisourceBergen's...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $1,295.32 for Mucinex D ER 600-60 mg tablets (18-count). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB25FUCH0Delivery Order
The Defense Logistics Agency awarded a $2,392.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Guaifenesin-PSE ER 600-60 mg tablets (18 count) on September 23, 2025, with completion scheduled for September 24, 2025. This non-set-aside, competitively awarded delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime contract running through December 2026 that serves as the comprehensive global pharmaceutical support mechanism for military healthcare systems worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contractor's extensive portfolio of DLA delivery orders demonstrates capability across diverse pharmaceutical categories including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This particular delivery order for the over-the-counter decongestant and expectorant combination falls within the company's established role as a primary supplier supporting military and veteran healthcare operations through the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 9/23/25 |